Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ -- ...
GenScript, founded in 2002 in New Jersey, has announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's ...
Strategic investment reinforces Europe as a core pillar of GenScript's global R&Dand production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results